FBInvestor
Stocks / Erasca Inc
Institutional Ownership

Erasca Inc

CUSIP 29479A108COMERASQ1 2026

13D / 13G Filings
35
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
10.7%
Max % of class reported
Institutional Holders
217
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

35 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026T. Rowe Price Investment Management, Inc.13G/A5.7%16.11MSEC
2Jan 14, 2026Paradigm Biocapital Advisors LP13G5.3%15.16MSEC
3Nov 14, 2025Logos Global Management LP13G/A4.8%13.60MSEC
4Aug 14, 2025T. Rowe Price Investment Management, Inc.13G/A7.2%20.33MSEC
5Aug 14, 2025Frazier Life Sciences Public Fund, L.P.13G/A5.3%15.04MSEC
6Aug 14, 2025Logos Global Management LP13G5.3%15.10MSEC
7Aug 13, 2025Suvretta Capital Management, LLC13G5.1%14.50MSEC
8May 15, 2025Frazier Life Sciences Public Fund, L.P.13G/A8.0%22.58MSEC
9Feb 13, 2025Suvretta Capital Management, LLC13G/A4.4%12.32MSEC
10Feb 12, 2025Novartis Pharma AG13G/A4.4%12.31MSEC

25 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Erasca Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Frazier Life Sciences Management, L.P.24.68M$399.24M
2Blackrock, Inc.20.15M$326.05M
3Venrock Adviser, LLC16.38M$265.07M
4Rtw Investments, LP16.16M$261.42M
5Vivo Capital, LLC12.15M$196.61M
6Siren, L.L.C.11.24M$181.93M
7Logos Global Management LP11.15M$180.41M
8Paradigm Biocapital Advisors LP10.39M$168.15M
9State Street Corp9.30M$150.48M
10Arch Venture Management, LLC7.09M$114.74M